29
Participants
Start Date
August 14, 2024
Primary Completion Date
November 21, 2024
Study Completion Date
November 21, 2024
Probiotic Group
The intervention is a mixture of two probiotics: 1) Lactobacillus acidophilus GLA-14 and 2) Lactobacillus rhamnosus HN001. These products will be combined into a single capsule/sachet with a dose of approximately 10\^10 colony forming units (CFUs) of GLA-14 (ATCC SD5212) and HN001 (ATCC SD5675) in a 4:1 ratio, using similar doses as recent studies using this product.
Placebo Group
The placebo will of be Maltodextrin, a carbohydrate, packaged similarly to the intervention and having the same weight.
Callen-Lorde Community Health Center (CLCHC), Brooklyn
Callen-Lorde Community Health Center
OTHER
Columbia University
OTHER